This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1981 May-Jun;1(3):228-32.

doi: 10.1002/hep.1840010306.

Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside

G H Scullard, L L Andres, H B Greenberg, J L Smith, V K Sawhney, E A Neal, A S Mahal, H Popper, T C Merigan, W S Robinson, P B Gregory

PMID: 6169615
DOI: 10.1002/hep.1840010306

Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside

G H Scullard et al. Hepatology. 1981 May-Jun.

. 1981 May-Jun;1(3):228-32.

doi: 10.1002/hep.1840010306.

Authors

G H Scullard, L L Andres, H B Greenberg, J L Smith, V K Sawhney, E A Neal, A S Mahal, H Popper, T C Merigan, W S Robinson, P B Gregory

PMID: 6169615
DOI: 10.1002/hep.1840010306

No abstract available

PubMed Disclaimer

Similar articles

Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
Bassendine MF, Chadwick RG, Salmeron J, Shipton U, Thomas HC, Sherlock S. Bassendine MF, et al. Gastroenterology. 1981 May;80(5 pt 1):1016-22. Gastroenterology. 1981. PMID: 7009310 Clinical Trial.
Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.
Scullard GH, Pollard RB, Smith JL, Sacks SL, Gregory PB, Robinson WS, Merigan TC. Scullard GH, et al. J Infect Dis. 1981 Jun;143(6):772-83. doi: 10.1093/infdis/143.6.772. J Infect Dis. 1981. PMID: 6166691 Clinical Trial.
Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy.
Craxi A, Weller IV, Bassendine MF, Fowler MJ, Monjardino J, Thomas HC, Sherlock S. Craxi A, et al. Gut. 1983 Feb;24(2):143-7. doi: 10.1136/gut.24.2.143. Gut. 1983. PMID: 6852624 Free PMC article.
[Active chronic hepatitis caused by the B virus (ACH-B). Recent pathogenetic acquisitions and elements of serological, clinical and histopathological diagnosis].
Romeo F, Spina A, Cannaò G. Romeo F, et al. Recenti Prog Med. 1980 Dec;69(6):577-643. Recenti Prog Med. 1980. PMID: 6166032 Review. Italian. No abstract available.
Treatment of the chronic hepatitis B virus carrier state.
Lever AM. Lever AM. J Infect. 1988 May;16(3):221-9. doi: 10.1016/s0163-4453(88)97508-1. J Infect. 1988. PMID: 2456355 Review.

See all similar articles

Cited by

Virus replication and liver disease in chronic hepatitis B virus infection.
Alberti A, Tremolada F, Fattovich G, Bortolotti F, Realdi G. Alberti A, et al. Dig Dis Sci. 1983 Nov;28(11):961-6. doi: 10.1007/BF01311722. Dig Dis Sci. 1983. PMID: 6628155
Activities of arabinosyladenine monophosphate and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against ground squirrel hepatitis virus in vivo as determined by reduction in serum virion-associated DNA polymerase.
Smee DF, Knight SS, Duke AE, Robinson WS, Matthews TR, Marion PL. Smee DF, et al. Antimicrob Agents Chemother. 1985 Feb;27(2):277-9. doi: 10.1128/AAC.27.2.277. Antimicrob Agents Chemother. 1985. PMID: 2580482 Free PMC article.
Treatment of chronic hepatitis B with recombinant leukocyte interferon and cyanidanol.
Kanai K, Morioka S, Nakajima T, Ishii H, Tamakoshi K, Matsuda H, Matsumoto M, Mizushima N, Takehira Y. Kanai K, et al. Gastroenterol Jpn. 1988 Feb;23(1):44-8. doi: 10.1007/BF02918855. Gastroenterol Jpn. 1988. PMID: 3350278
Serum hepatitis B viral DNA in HBsAg-positive hepatocellular carcinoma treated with interferon or adriamycin.
Lin HJ, Lai CL, Wu PC. Lin HJ, et al. Br J Cancer. 1986 Jul;54(1):67-73. doi: 10.1038/bjc.1986.153. Br J Cancer. 1986. PMID: 3015183 Free PMC article.
In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.
Cullen JM, Smith SL, Davis MG, Dunn SE, Botteron C, Cecchi A, Linsey D, Linzey D, Frick L, Paff MT, Goulding A, Biron K. Cullen JM, et al. Antimicrob Agents Chemother. 1997 Oct;41(10):2076-82. doi: 10.1128/AAC.41.10.2076. Antimicrob Agents Chemother. 1997. PMID: 9333028 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

Grants and funding

AI 42527/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information